Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice.
D000818:Animals; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000493:pharmacokinetics / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008549:Melarsoprol / Q000494:pharmacology; D051379:Mice; D016513:Mice, SCID; D009101:Multiple Myeloma / Q000188:drug therapy*; D009368:Neoplasm Transplantation / Q000379:methods; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010087:Oxides / Q000493:pharmacokinetics / Q000494:pharmacology*; D010950:Plasma Cells / Q000166:cytology / Q000187:drug effects; D019947:Receptors, Interleukin-6 / Q000097:blood; D016019:Survival Analysis; D014018:Tissue Distribution; D023041:Xenograft Model Antitumor Assays
D001152:Arsenicals; D007074:Immunoglobulin G; D010087:Oxides; D019947:Receptors, Interleukin-6; D000077237:Arsenic Trioxide; D008549:Melarsoprol